Ascletis Pharma Future Growth

How is Ascletis Pharma forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

Future Growth Score

2/6

Future Growth Score 2/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


26.6%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

SEHK:1672 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2024319-87N/AN/A2
12/31/2023210-173N/AN/A2
12/31/202285-246N/AN/A1
6/30/202279-176-147-129N/A
3/31/202278-188-150-138N/A
12/31/202177-199-154-147N/A
9/30/202158-234-172-150N/A
6/30/202140-269-190-153N/A
3/31/202137-239-157-119N/A
12/31/202035-209-124-85N/A
9/30/202082-155-86-56N/A
6/30/2020130-100-47-28N/A
3/31/2020152-98-75-51N/A
12/31/2019173-96-103-74N/A
9/30/2019150-92-130-91N/A
6/30/2019127-89-157-107N/A
3/31/2019153-43-146-83N/A
12/31/2018166-7-157-97N/A
9/30/2018154-5-172-134N/A
6/30/2018142-2-188-171N/A
3/31/201891-40-243-210N/A
12/31/201753-54-234-198N/A
12/31/201633-27-57-12N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 1672 is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: 1672 is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: 1672 is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: 1672's revenue (59.4% per year) is forecast to grow faster than the Hong Kong market (9.5% per year).

High Growth Revenue: 1672's revenue (59.4% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 1672 is forecast to be unprofitable in 3 years.


Discover growth companies